Devika Gajria

Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer

Azael Freites‐Martínez, Jerry Shapiro, Donald Chan et al. · JAMA Dermatology · 2018 · 106 citations · Full text

A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors

Clifford A. Hudis, Charles Swanton, Yelena Y. Janjigian et al. · Breast Cancer Research · 2013 · 102 citations · Full text

Phase II Study of Paclitaxel Given Once per Week Along With Trastuzumab and Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Chau T. Dang, Neil M. Iyengar, Farrah Mikhail Datko et al. · Journal of Clinical Oncology · 2014 · 78 citations · Full text

Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia

Azael Freites‐Martínez, Donald Chan, V. Sibaud et al. · JAMA Dermatology · 2019 · 72 citations

Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia

Olatoyosi Odenike, Richard A. Larson, Devika Gajria et al. · Investigational New Drugs · 2008 · 50 citations · Full text

Hematological Malignancy, Oncology, Medicine +10